Prestige Consumer Healthcare Inc
NYSE:PBH
Prestige Consumer Healthcare Inc
Selling, General & Administrative
Prestige Consumer Healthcare Inc
Selling, General & Administrative Peer Comparison
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Prestige Consumer Healthcare Inc
NYSE:PBH
|
Selling, General & Administrative
-$254m
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-6%
|
|
Johnson & Johnson
NYSE:JNJ
|
Selling, General & Administrative
-$20.6B
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
1%
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Selling, General & Administrative
-$7.7B
|
CAGR 3-Years
0%
|
CAGR 5-Years
-11%
|
CAGR 10-Years
-5%
|
|
Pfizer Inc
NYSE:PFE
|
Selling, General & Administrative
-$14.4B
|
CAGR 3-Years
-9%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
0%
|
|
Merck & Co Inc
NYSE:MRK
|
Selling, General & Administrative
-$10.4B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
1%
|
|
Eli Lilly and Co
NYSE:LLY
|
Selling, General & Administrative
-$7.4B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
0%
|
See Also
What is Prestige Consumer Healthcare Inc's Selling, General & Administrative?
Selling, General & Administrative
-254m
USD
Based on the financial report for Dec 31, 2023, Prestige Consumer Healthcare Inc's Selling, General & Administrative amounts to -254m USD.
What is Prestige Consumer Healthcare Inc's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 10Y
-6%
Over the last year, the Selling, General & Administrative growth was 2%. The average annual Selling, General & Administrative growth rates for Prestige Consumer Healthcare Inc have been -3% over the past three years , -2% over the past five years , and -6% over the past ten years .